Provectus Biopharmaceuticals, Inc.
PVCT
$0.05
$0.00-0.75%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.16M | 223.90K | 251.30K | 75.00K | 385.90K |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 174.70K | 181.40K | 243.60K | 112.20K | 147.40K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 37.30K | 55.10K | 73.00K | 90.80K | 34.90K |
| Total Current Assets | 1.37M | 460.40K | 567.90K | 278.00K | 568.30K |
|
|
|||||
| Total Current Assets | 1.37M | 460.40K | 567.90K | 278.00K | 568.30K |
| Net Property, Plant & Equipment | 104.60K | 117.20K | 129.60K | 141.90K | 154.10K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 1.47M | 577.60K | 697.50K | 419.90K | 722.40K |
|
|
|||||
| Total Accounts Payable | 932.00K | 815.30K | 716.20K | 1.18M | 1.31M |
| Total Accrued Expenses | 3.32M | 3.73M | 3.31M | 2.97M | 2.77M |
| Short-term Debt | 92.40K | 161.30K | 217.80K | 105.90K | 54.30K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.36M | 2.54M | 2.66M | 2.22M | 2.36M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 7.71M | 7.24M | 6.90M | 6.47M | 6.49M |
|
|
|||||
| Total Current Liabilities | 7.71M | 7.24M | 6.90M | 6.47M | 6.49M |
| Long-Term Debt | -- | -- | 23.60K | 23.60K | -- |
| Short-term Debt | 92.40K | 161.30K | 217.80K | 105.90K | 54.30K |
| Capital Leases | 53.90K | 66.60K | 79.20K | 91.60K | 103.90K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 7.76M | 7.31M | 7.00M | 6.59M | 6.60M |
|
|
|||||
| Common Stock & APIC | 258.90M | 257.46M | 256.60M | 255.58M | 254.55M |
| Retained Earnings | -265.13M | -264.14M | -262.85M | -261.69M | -260.38M |
| Treasury Stock & Other | -59.80K | -59.90K | -60.20K | -60.30K | -60.40K |
| Total Common Equity | -6.29M | -6.74M | -6.31M | -6.17M | -5.89M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 15.70K | 15.30K | 15.10K | 14.90K | 14.70K |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 15.70K | 15.30K | 15.10K | 14.90K | 14.70K |
|
|
|||||
| Total Common Equity | -6.29M | -6.74M | -6.31M | -6.17M | -5.89M |
| Total Preferred Equity | 15.70K | 15.30K | 15.10K | 14.90K | 14.70K |
| Total Minority Interest | -12.40K | -6.20K | -4.00K | -16.20K | -3.80K |
| Total Equity | -6.29M | -6.73M | -6.30M | -6.17M | -5.87M |
|
|
|||||